Accumulating evidence suggests critical roles of epigenetic mechanisms, including both histone and DNA modifications, in neuronal plasticity, neurogenesis and neurological and psychiatric disorders [1] [2] [3] [4] [5] [6] [7] [8] . Cytosine methylation is the predominant covalent modification of eukaryotic genomic DNA and regulates transcription in a highly cell type-and genomic context-dependent manner 9, 10 . In vertebrates, DNA methylation is established and maintained by a conserved family of DNMTs 9 and can be removed in both passive and active manners 11 . The functions of DNA methylation, especially transcriptional repression, are mediated in part by a family of methylated DNA binding proteins 12 . Mutations in MeCP2, a well-characterized CpG methylation reader that is highly expressed in mature neurons, lead to deficits in neural development and neuronal functions and are causally linked to Rett syndrome, a severe neurodevelopmental disorder in humans 13, 14 .
Accumulating evidence suggests critical roles of epigenetic mechanisms, including both histone and DNA modifications, in neuronal plasticity, neurogenesis and neurological and psychiatric disorders [1] [2] [3] [4] [5] [6] [7] [8] . Cytosine methylation is the predominant covalent modification of eukaryotic genomic DNA and regulates transcription in a highly cell type-and genomic context-dependent manner 9, 10 . In vertebrates, DNA methylation is established and maintained by a conserved family of DNMTs 9 and can be removed in both passive and active manners 11 . The functions of DNA methylation, especially transcriptional repression, are mediated in part by a family of methylated DNA binding proteins 12 . Mutations in MeCP2, a well-characterized CpG methylation reader that is highly expressed in mature neurons, lead to deficits in neural development and neuronal functions and are causally linked to Rett syndrome, a severe neurodevelopmental disorder in humans 13, 14 .
In metazoan genomes, cytosine methylation is thought to be restricted largely to the CpG dinucleotide, which facilitates mitotic transmission of the methylation pattern 15, 16 . Notably, both the maintenance DNMT (DNMT1) and de novo DNMTs (DNMT3A and DNMT3B) have been shown to methylate non-CpG cytosines in vitro 17, 18 . Previous studies have shown that CpH methylation is present in cultured pluripotent stem cells, including embryonic stem cells (ESCs) and induced pluripotent stem cells [19] [20] [21] [22] [23] [24] , as well as in the mouse germ line [25] [26] [27] , but is absent in most somatic tissues 19, 23 .
Several recent profiling studies have shown the presence of CpH methylation in the adult mouse cortex 28, 29 and human brain 29, 30 , which consist of mixtures of many neural subtypes. These observations raise important questions. For example, does CpH methylation have any roles in transcriptional regulation in mammalian cells, and if so, what protein readers may recognize CpH methylation? In addition, little is known about the enzymatic mechanisms that establish and maintain CpH methylation in neurons.
Here we generated the single base-resolution neuronal DNA methylation profile of the adult mouse dentate gyrus and characterized the genomic distribution of CpH methylation. We further demonstrated that CpH methylation is conserved in human brains in orthologous genes. Using a plasmid reporter system, we showed that CpH methylation could cause transcriptional repression in mouse neurons. Notably, MeCP2 bound to mCpH both in vitro and in neurons in vivo. In addition, we found that CpH methylation was established postnatally during neuronal maturation and required DNMT3A for its active maintenance in neurons in vivo.
RESULTS
Single base-resolution neuronal DNA methylome To systematically characterize the in vivo neuronal methylome, we purified genomic DNA from a relatively homogeneous population of granule neurons from the adult mouse dentate gyrus [31] [32] [33] and a r t I C l e S performed whole-genome bisulfite sequencing (Bisulfite-Seq) for two biological replicates. We obtained a total of ~43 Gb of sequences (2 × 100-bp paired-end reads; ~16× coverage per strand) that were uniquely mapped to the in silico bisulfite-converted mouse genome with no mismatch. To identify significantly methylated cytosines genome wide, we used a stringent binomial distribution-based filter to eliminate false positives from incomplete bisulfite conversion and sequencing errors. Our analysis pipeline confirmed the previous finding that CpH methylation is present in human ESCs but not fibroblasts 20 (data not shown). Notably, our analysis also revealed that ~25% of all methylated cytosine loci in the adult mouse dentate neuronal genome were mCpHs (Fig. 1a) , which consisted of ~4% mCHGs and ~21% mCHHs, with mCHGs being under-represented (P < 10 −15 , χ 2 test). Global CpG and CpH methylation levels were similar among autosomes, whereas sex chromosomes exhibited the lowest levels of CpH methylation (Supplementary Fig. 1 ). Methylation levels of individual mCpHs and mCpGs between two biological replicates were highly correlated (Supplementary Fig. 2) .
We next selected a group of loci with high levels of CpH methylation for more detailed analyses. Bisulfite conversion-independent measurements using a methylation-dependent restriction enzyme, FspEI, which selectively digests C m C motifs 34 , confirmed the presence of mCpH in the adult dentate gyrus (Fig. 1b and Supplementary  Table 1a) . Sanger bisulfite sequencing in independent samples also confirmed the presence of CpH methylation at selected loci in the adult mouse dentate gyrus ( Fig. 1c and Supplementary Table 1b) . CpH methylation at these loci was virtually absent in mouse spleen, whereas methylation of the examined CpG loci was largely conserved (Fig. 1c) . In contrast to CpG methylation, CpH methylation was apparently heterogeneous among different alleles from a homogenous population of neurons, although it did not segregate clearly into hypermethylated and hypomethylated alleles (Fig. 1c) . To exclude the potential contribution from non-neuronal cells, such as neural progenitors, astrocytes and oligodendrocytes, we analyzed the genomic DNA of fluorescence-activated cell sorting (FACS)-purified NeuN + neuronal nuclei from the adult dentate gyrus 33 and observed similar levels of CpG and CpH methylation (Fig. 1c) . Therefore, our study comprehensively and reliably identified a large number of mCpHs in the adult mouse dentate neuronal DNA methylome in vivo.
Conservation of CpH methylation in adult human brains
To examine whether neuronal CpH methylation identified in mouse genomic DNA was conserved in other mammals, we performed Sanger bisulfite sequencing in the orthologous genomic regions using adult human brain and spleen DNA samples (Supplementary Table 1c ). Despite that most of these regions exhibited different CpG patterns, we observed highly reproducible levels of CpH and CpG methylation in all orthologous regions examined using adult human brain genomic DNA from different individuals but not using spleen DNA (Fig. 2a,b) , suggesting the evolutionary conservation of neuronal CpH methylation.
To extend this finding to the genome scale, we analyzed the reduced representation bisulfite sequencing (RRBS) data generated by the Encyclopedia of DNA Elements (ENCODE) consortium 30 and observed much higher global levels of CpH methylation in the human brain and placenta than in other somatic tissues (Fig. 2c) . We then focused on genes with clear one-to-one orthologs in human and mouse (15,417 ortholog pairs in total) and quantified the degree of overlap of CpH-methylated genes (genes that contained ≥2 mCpHs with ≥25% methylation levels) in human and mouse brains. Although RRBS did not provide high coverage genome wide, and therefore fewer genes were identified as being CpH methylated in the human brain than in the mouse brain, a majority (~83%) of the human CpH-methylated genes had orthologs that were also CpH-methylated in the mouse brain (Fig. 2d) . Together these results indicate not only that CpH methylation widely exists in mammalian neurons but also that it marks conserved sets of genes in both mice and humans.
Genomic features of neuronal CpH methylation
To characterize the genome-wide distribution of CpH methylation in adult dentate neurons, we focused on high-coverage (≥20×) cytosines for detailed bioinformatic analyses. Unlike individual mCpGs, which exhibited a bimodal distribution of methylation levels, we observed intermediate methylation levels (mostly ~25%) in most mCHGs and mCHHs (Fig. 3a) , suggesting that only a fraction of all alleles were methylated at the steady state. Although most mCHGs and mCHHs were adjacent to highly methylated CpGs (Supplementary Fig. 3a) , a chromosome-wide view of three classes of cytosine methylation npg a r t I C l e S (CpG, CHG and CHH) showed that the correlation between CHG and CHH methylation was much higher than that between CpG and CpH methylation ( Fig. 3c and Supplementary Fig. 3 ), mostly because of regions with high levels of CpG methylation but low levels of CpH methylation. Motif analysis identified a prominent CAC preference for CpH methylation in neurons (Fig. 3b) . The preference for adenine at the +1 position would predict asymmetric methylation patterns on two DNA strands. Indeed, although genome-wide CpG methylation on two strands was highly correlated, the correlations were much weaker for CHG and CHH methylation ( Supplementary Fig. 4a ). Also as predicted by the CpA preference, for each mCHG (mostly CAG), the cytosine at the +2 position in the opposite strand (mostly CTG) was rarely methylated (Supplementary Fig. 4b ).
In contrast to the distinct spacing patterns of mCHG and mCHH found in ESCs 23 , the same analysis showed a similar 8-bp spacing for both mCHGs and mCHHs in neurons ( Fig. 3d and Supplementary  Fig. 5 ), suggesting a common mechanism regulating CHG and CHH methylation in neurons. In addition, we observed a periodicity of ~180 bp for neuronal mCpHs (Fig. 3d) , supporting previous findings on the relationship between DNA methylation and nucleosome positioning 35 . Notably, mCpHs preferentially resided in regions of low CpG density (Fig. 3e) , with ~8% of mCpHs having no neighboring CpGs within 500-bp flanking sequences, raising the possibility of a mCpG-independent role for mCpHs in these regions of low CpG density.
Anticorrelation between mCpH and gene expression
To begin to understand the potential function of CpH methylation in neurons, we first examined its relationship with neuronal protein-DNA interactions. Both CpGs and CpHs were hypomethylated around neuronal transcription factor binding sites that have been identified previously in neurons 36 ( Fig. 4a and Supplementary Table 2 ), suggesting that protein-DNA interactions exhibit similar effects on CpGs and CpHs in preventing de novo DNA methylation and/or causing active DNA demethylation 30 . In contrast, hypomethylation of neuronal DNA at ESC-specific transcription factor binding sites 37 was much less pronounced in neurons ( Supplementary  Fig. 6 ). Similar to around neuronal transcription factor binding sites, both CpGs and CpHs were hypomethylated around transcription start sites (TSSs; Fig. 4b ).
To further understand the potential role of CpH methylation in transcriptional regulation, we profiled gene expression in the adult mouse dentate gyrus by mRNA-Seq (~92 million reads from three biological replicates). In contrast to ESCs 23 and consistent with previous results from a mixed population of neural cells 28, 29 , both e r L u n g P a n c r e a s P e r ic a r d iu m P la c e n t a S k in S t o m a c h T e s t is npg a r t I C l e S neuronal CpG and CpH methylation anticorrelated with the associated gene expression levels throughout the 5′-upstream, gene-body and 3′-downstream regions in dentate granule neurons (Fig. 4b) . To minimize the contribution from nearby mCpGs, we focused on the ~8%, or 70,364, mCpHs that did not have any neighboring CpGs within 500-bp flanking sequences (Fig. 3e) . Of these CpG-far mCpHs, 395, 410 and 440 were located within 2 kb of extragenic enhancers, intragenic enhancers 36 and TSSs, respectively. Notably, these mCpH-containing regulatory regions located far from CpGs were also associated with significantly lower nearest-gene expression levels as compared to corresponding background gene sets (P < 2 × 10 −16 ; Supplementary Fig. 7 ), further suggesting a potential function of CpH methylation in transcriptional repression.
Repression of reporter gene expression by mCpH
To assess directly the intrinsic capacity of CpH methylation in transcriptional repression, we modified a well-established quantitative reporter assay using in vitro methylated plasmids 31, 32, 38, 39 . We methylated GFP-expressing plasmids at specific locations using a panel of bacterial DNMTs before co-transfection with unmethylated RFP expression plasmids into HEK293 cells (Supplementary Fig. 8a ) or cultured mouse hippocampal neurons (Fig. 5a) . Notably, with the same density of methylated cytosine, CpH methylation by M.MspI ( m CCGG) caused a similar degree of repression compared to CpG methylation by M.HpaII (C m CGG; Fig. 5b and Supplementary Fig. 8b ).
In addition, GpC methylation by M.CviPI (G m C), most of which resided in the CpH context, caused similar repression as CpG methylation by M.SssI ( m CG; Fig. 5b and Supplementary Fig. 8b ). The strong repression caused by GpC methylation was not due simply to the overlapping CpGs (G m CGs), as the repression caused by M.SssIcatalyzed CpG methylation could be further strengthened by either M.MspI or M.CviPI methylation (Supplementary Fig. 8b ). None of these methylation patterns showed detectable effects on transfection efficiencies ( Fig. 5b and Supplementary Fig. 8b ). Bisulfite sequencing of plasmid DNA recovered after transfection showed high efficiencies of all types of in vitro methylation and no de novo CpG methylation in CpH-methylated plasmids (Supplementary Fig. 8c ), indicating that CpH methylation did not repress GFP expression indirectly by inducing CpG methylation. Although in vitro methylation did not fully recapitulate endogenous CpH methylation patterns, these results suggested that mCpGs and mCpHs both have the intrinsic capacity to repress transcription in mammalian cells, including in neurons.
Recognition of mCpH by MeCP2 in vitro and in vivo
MeCP2 has been well established to recognize mCpGs and regulate gene expression in the nervous system 13, 14 . Across the genome, both CpGs and CpHs were hypermethylated near MeCP2-bound regions that were previously determined by chromatin immunoprecipitation (ChIP) in neurons 40 (Fig. 6a) . We directly tested the binding capacity of recombinant MeCP2 protein to synthetically methylated oligonucleotides by electrophoretic mobility shift assay (EMSA). MeCP2 exhibited clear binding to mCpG-containing oligonucleotides (Fig. 6b) . Notably, MeCP2 also bound to CpH-methylated oligonucleotides with a lower affinity in the absence of any mCpGs. Furthermore, the presence of both mCpGs and mCpHs greatly enhanced MeCP2 binding (Fig. 6b) . In contrast, another methyl-CpG binding domain (MBD) protein, MBD2b, exhibited higher selectivity toward mCpGs and bound minimally to CpH-methylated oligonucleotides in this assay, although the coexistence of mCpGs and mCpHs also enhanced MBD2b binding (Supplementary Fig. 9 ). To determine physiologically whether endogenous MeCP2 recognizes mCpHs in vivo, we examined the methylation patterns of endogenous MeCP2-bound DNA by bisulfite sequencing of the MeCP2 ChIP DNA from the adult mouse hippocampus. Consistent with previous studies 40 , MeCP2 ChIP selectively enriched CpG-methylated alleles at a given locus (Fig. 6c) . Notably, CpH-methylated regions Figure 7 shows the anticorrelation between CpH methylation in locations far from CpGs in regulatory regions and gene expression. npg a r t I C l e S that were depleted of CpGs were also highly enriched in the MeCP2-bound chromatin (Fig. 6c) , supporting the in vivo interaction between MeCP2 and mCpHs in neurons.
mCpH establishment and maintenance in vivo
We next examined the developmental timing of CpH methylation in neurons. Consistent with a recent study of the cortex 29 , timecourse analyses revealed that CpH methylation at the selected loci was established during postnatal development of the hippocampus and was then present throughout life, whereas CpG methylation was established during early development (Fig. 7a) . Maturing mouse hippocampal neurons in vitro also showed a gradual increase in CpH, but not CpG, methylation over time (Fig. 7b) . Furthermore, CpH methylation levels in the adult human brain DNA were much higher than those in fetal brain samples and in adult and fetal human heart DNA (Fig. 7c) . Together these results indicate that, in contrast to most CpG methylation 25 , CpH methylation is established during postnatal neuronal maturation in both mouse and human brains.
We then examined the regulation of CpH methylation in postmitotic neurons in vivo. Conditional neuronal triple knockout of Dnmt1, Dnmt3a and Dnmt3b (CamKIIα-Cre) led to a preferential loss of CpH methylation in the postnatal hippocampus, whereas CpG methylation was only modestly reduced, as has been observed previously 41 (Fig. 8a) . Among the three DNMTs, DNMT1 and DNMT3A are expressed at higher levels in postmitotic neurons 41 . To determine their individual roles in maintaining neuronal CpH methylation in vivo, we injected adeno-associated viruses (AAVs) expressing short hairpin RNAs (shRNAs) that specifically targeted DNMT1 or DNMT3A into the dentate gyrus of adult wild-type mice (Supplementary Fig. 10 ). DNMT3A knockdown led to a significant reduction in CpH, but not CpG, methylation at these loci, whereas DNMT1 knockdown showed little effect (Fig. 8b) . Notably, the preferential loss of CpH methylation caused by DNMT3A knockdown was accompanied by the significant derepression of the mRNA expression of these CpH-methylated genes (Fig. 8c) , whereas we observed no methylation or mRNA expression changes in a unmethylated gene (Bdnf IV) or CpG-methylated and CpH-unmethylated genes (Bdnf IX and Fgf1B; Supplementary Fig. 11 ). Furthermore, DNMT3A ChIP analysis showed that CpH-methylated regions were bound by DNMT3A in dentate neurons in vivo (Supplementary Fig. 12 and Supplementary Table 1e ). These results strongly support a physiological role of CpH methylation in the repression of gene expression 
Lrba (+) P = 7.2 × 10 -6 P 1 P 3 P 7 P 2 0 P 5 6 1 y e a r 2 y e a r s E 1 2 P 1 P 3 P 7 P 2 0 P 5 6 1 y e a r 2 y e a r s npg a r t I C l e S in neurons in vivo. To examine whether differences in de novo DNMT expression could explain the brain-specific accumulation of CpH methylation, we measured the relative expression levels of DNMTs in a variety of mouse tissues. Surprisingly, we found a similar expression level of DNMT3A and much lower expression levels of DNMT3A2 and DNMT3B in the brain compared to in other tissues without CpH methylation (Supplementary Fig. 13 ). Collectively these results suggest that continuous DNMT3A expression is required but not sufficient to accumulate neuronal CpH methylation in vivo.
DISCUSSION
Our systematic analysis of the in vivo neuronal methylome from the adult mouse dentate gyrus at single-base resolution and subsequent mechanistic studies generated new insights into the genomic features, conservation, potential function, reader and regulator of CpH methylation in the adult mammalian brain. Given that CpGs only represent 4% of the metazoan genome, CpH methylation greatly expands the proportion of the neuronal genome that is subject to regulation by cytosine methylation and is a new mechanism of neuronal transcription regulation. Our study provided a number of findings that have important implications for the future understanding of this epigenetic modification in the nervous system. In contrast to previous profiling studies [28] [29] [30] , we obtained single base-resolution DNA methylomes from in vivo adult dentate gyrus preparations, with the vast majority of cells consisting of a single neuronal subtype, thereby providing a unique resource for the field. In adult dentate neurons, CpH methylation accounted for ~25% of all methylated cytosines, which is similar to recent findings in the mouse cortex 28 and human pluripotent stem cells in vitro [19] [20] [21] [22] [23] [24] . Our study revealed some clear distinctions between mCpHs in the brain and those in pluripotent stem cells (Supplementary Fig. 14) . For example, the preference of mCHGs over mCHHs and the 8-, 21-, 29-bp spacing pattern of mCHGs in proliferating pluripotent stem cells 23 are absent in postmitotic neurons. Instead, their highly correlated genomic distributions, identical 8-bp spacing (reminiscent of the DNMT3A-DNMT3L complex 42 ) and requirement for DNMT3A for active maintenance suggest that mCHG and mCHH are similarly regulated in neurons. Although the bisulfite sequencing approach does not differentiate between methylated cytosine and hydroxymethylcytosine (hmC), the vast majority of steady-state mCpHs are unlikely to be hydroxymethylated. Recent single base-resolution hmC studies have shown very low levels of hmCpHs in pluripotent stem cells and in the brain 29, 43, 44 . In addition, mCpHs and hmCs exhibit opposite correlations with gene expression [43] [44] [45] .
Our study provides the first evidence, to our knowledge, of the potential function of CpH methylation in the nervous system. In a plasmid reporter assay, mCpHs were sufficient to repress gene transcription in cultured neurons as effectively as mCpGs. Although in vitro methylation was complete and symmetric, whereas endogenous CpH methylation was mostly intermediate and asymmetric, our results suggest an intrinsic capacity of mCpHs to repress transcription independently of CpG contexts. The derepression of CpH-methylated genes after DNMT3A knockdown, which preferentially decreased CpH, but not CpG, methylation provided physiological evidence for a critical role of CpH methylation in repressing gene expression in vivo. We further showed a genome-wide anticorrelation between CpH methylation levels and the associated gene expression, including mCpHs in regulatory genomic regions without any nearby CpGs.
Recent studies have shown dynamic changes of neuronal DNA methylation in development, maturation, plasticity, learning memory and brain disorders 7, 8 . Notably, both CpGs and CpHs are substrates for methylation 46, 47 and demethylation 32 . Our results suggest that mCpHs are a more dynamic population in the neuronal DNA methylome in vivo. When de novo DNMT activities were decreased, CpH methylation was preferentially lost before CpG methylation showed any changes. The apparently higher turnover of mCpHs than mCpGs could be due to either or both of two possibilities. First, demethylation of mCpHs could be more efficient than that of mCpGs. Our previous in vitro study using fully hydroxymethylated DNA indicated that hmCpHs were more efficiently demethylated than hmCpGs by approximately fourfold in mammalian cells 32 . Second, remethylation of CpG could be more efficient than that of CpH. Because demethylation is mediated by a base-excision repair mechanism in a strand-specific manner 32 , demethylation of mCpG would first generate a hemimethylated CpG, which could be a Lrba (+) Figure 11 shows the results for unmethylated and CpG-methylated and CpH-unmethylated genes.
a r t I C l e S readily remethylated by DNMT1. In contrast, mCpH, once demethylated, can only be remethylated de novo by DNMT3A. The apparent heterogeneous methylation patterns of mCpHs in neurons (Fig. 3a) may be a result of their dynamic turnover, with only a fraction of all alleles captured in the methylated status at the steady state. It will be interesting for future studies to address how DNMT3A and DNA demethylases are targeted specifically to mCpH loci and the biological importance of the dynamic turnover of mCpHs in the neuronal gene expression program. It also remains to be investigated to what extent CpH methylation mediates the unique and essential role of DNMT3A in postnatal development and functions of the nervous system 41, 48 . Notably, DNMT3A has been shown to regulate emotional behavior and spine plasticity in the nucleus accumbens 49 . Our study pinpointed the developmental timing of CpH methylation during neuronal maturation and identified MeCP2 as the first mCpH binding protein in vitro and in vivo. Despite the widely recognized importance of MeCP2 as a DNA methylation reader for mCpGs 50 and, more recently, for hmCpGs 45 , little is known about how it actually reads DNA methylation on a fine scale. Our results from the in vitro binding assay and in vivo ChIP bisulfite sequencing assays shed light onto this fundamental question directly. Interestingly, the timing of the postnatal onset of Rett syndrome coincides with the emergence of CpH, but not CpG, methylation in neurons. Our finding of a strong influence of mCpH on MeCP2 binding in neurons in vivo indicates a new direction for understanding the biology of MeCP2 and the mechanisms underlying MeCP2-related mental disorders.
Cytosine methylation has critical roles in regulating gene expression under both physiological and pathological conditions. Although CpG methylation occurs more frequently on average across the genome, large fractions of mammalian genomes are devoid of CpGs. Our observation of preferential CpH methylation in these CpG-depleted regions suggests that CpH methylation might compensate at least partially for the lack of CpGs and increase the local density of methylated cytosine in neurons without adding constitutively methylated new CpG dinucleotides in the genome. We observed such a compensatory effect not only in the transcriptional regulatory effects of mCpGs and mCpHs but also in MeCP2 binding, which was greatly enhanced when mCpG and mCpH were adjacent to each other. In summary, CpH methylation greatly expands the proportion of the neuronal genome that is under regulation by cytosine methylation and is a new layer of epigenetic modulation of the neuronal genome. The newly identified characteristics of CpH methylation point to new directions for future understanding of this epigenetic modification in neuronal identity, development and plasticity and in psychiatric and neurological disorders.
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